You want to charge $1M for that gene therapy? Here’s where you’re wrong – Endpoints News
Endpoints News |
You want to charge $1M for that gene therapy? Here's where you're wrong
Endpoints News Spark Therapeutics $ONCE doesn't have a green light yet from the FDA to sell its gene therapy for one small group of patients with a genetic flaw that causes inherited blindness. And company execs haven't told anyone exactly what its wholesale price … |
